硫酸奎尼丁的全球市場 2022-2026年

據本報告預測硫酸奎尼丁的市場規模在2022年～2026年間，預測將成長到4億2,729萬美元，在預測期間內預計將以年複合成長率6.7％增長。

本報告提供奎尼丁錠硫酸市場相關資料，整體分析，提供市場規模與預測，趨勢，成長促進因素，課題，網羅了約25供應商的供應商分析等資訊。

同時本報告還提供當前全球市場趨勢與推動因素以及整體市場環境的最新分析。對當前全球市場趨勢和驅動因素以及整體市場環境的最新分析。市場受到瘧疾發病率上升、強大的管道和藥物批准以及併購增加推動了該市場的成長。

該研究指出，抗擊瘧疾的強大資金是未來幾年推動硫酸奎尼丁市場增長的主要原因之一。此外，心律失常發病率的增加和公眾對硫酸奎尼丁補充劑的認識的提高也將促進市場需求旺盛。

目錄

第1章 摘要整理

• 市場概要

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 市場區隔分析
• 市場規模 2021
• 市場預測:2021-2026年的預測

第4章 波特的五力分析

• 五力的摘要
• 買方議價能力
• 供給企業談判力
• 新加入廠商業者的威脅
• 替代品的威脅
• 競爭的威脅
• 市場情況

第5章 各疾病類型的市場區隔

• 市場明細
• 各疾病比較
• 瘧疾 - 市場規模與預測 2021-2026
• 心律不整 - 市場規模與預測 2021-2026
• 各疾病的市場機會

第6章 客戶形勢

• 客戶形勢概要

第7章 各地區形勢

• 各地區市場區隔
• 各地區比較
• 北美 - 市場規模與預測 2021-2026
• 歐洲 - 市場規模與預測 2021-2026
• 亞洲 - 市場規模與預測 2021-2026
• 其他地區(ROW) - 市場規模與預測 2021-2026
• 美國 - 市場規模與預測 2021-2026
• 德國 - 市場規模與預測 2021-2026
• 中國 - 市場規模與預測 2021-2026
• 英國 - 市場規模與預測 2021-2026
• 加拿大 - 市場規模與預測 2021-2026
• 各地區形勢的市場機會

第8章 原動力，課題，及的趨勢

• 推動市場要素
• 市場課題
• 推動要素與課題的影響
• 市場趨勢

第9章 業者情勢

• 概要
• 業者情勢
• 混亂形勢
• 產業的風險

第10章 供應商分析

• 交易廠商
• 供應商的市場定位
• Bennet Pharmaceuticals Ltd.
• Buchler GmbH
• Cipla Ltd.
• Ipca Laboratories Ltd.
• Lark Laboratories India Ltd.
• Merck and Co. Inc.
• Merck KGaA
• PRISM INDUSTRIES LTD.
• Teva Pharmaceutical Industries Ltd.
• VIVAN Life Sciences Pvt. Ltd.

第11章 附錄

Technavio has been monitoring the quinidine sulfate market and it is poised to grow by $ 427.29 mn during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period. Our report on the quinidine sulfate market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing incidence of malaria, robust pipeline and drug approvals, and increasing mergers and acquisitions.

The quinidine sulfate market analysis includes type segment and geographic landscape.

Technavio's quinidine sulfate market is segmented as below:

By Type

• Malaria
• Arrhythmias

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the strong funding for the eradication of malaria as one of the prime reasons driving the quinidine sulfate market growth during the next few years. Also, an increase in the incidence of arrhythmia and increasing awareness among people about quinidine sulfate supplements will lead to sizable demand in the market.

• Quinidine sulfate market sizing
• Quinidine sulfate market forecast
• Quinidine sulfate market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading quinidine sulfate market vendors that include Bennet Pharmaceuticals Ltd., Buchler GmbH, Cipla Ltd., Ipca Laboratories Ltd., Lark Laboratories India Ltd., Merck and Co. Inc., Merck KGaA, PRISM INDUSTRIES LTD., Teva Pharmaceutical Industries Ltd., VIVAN Life Sciences Pvt. Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Inga Laboratories P. Ltd., Koninklijke DSM NV, PMC Group Inc., PT Bio Farma, PT Sinkona Indonesia lestar, and Vital Laboratories Pvt. Ltd. Also, the quinidine sulfate market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Disease Type

• 5.1 Market segments
• Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
• 5.2 Comparison by Disease Type
• Exhibit 26: Chart on Comparison by Disease Type
• Exhibit 27: Data Table on Comparison by Disease Type
• 5.3 Malaria - Market size and forecast 2021-2026
• Exhibit 28: Chart on Malaria - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Malaria - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Malaria - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Malaria - Year-over-year growth 2021-2026 (%)
• 5.4 Arrhythmias - Market size and forecast 2021-2026
• Exhibit 32: Chart on Arrhythmias - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Arrhythmias - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Arrhythmias - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Arrhythmias - Year-over-year growth 2021-2026 (%)
• 5.5 Market opportunity by Disease Type
• Exhibit 36: Market opportunity by Disease Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.9 China - Market size and forecast 2021-2026
• Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.10 UK - Market size and forecast 2021-2026
• Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.11 Canada - Market size and forecast 2021-2026
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification
• 10.3 Bennet Pharmaceuticals Ltd.
• Exhibit 85: Bennet Pharmaceuticals Ltd. - Overview
• Exhibit 86: Bennet Pharmaceuticals Ltd. - Product / Service
• Exhibit 87: Bennet Pharmaceuticals Ltd. - Key offerings
• 10.4 Buchler GmbH
• Exhibit 88: Buchler GmbH - Overview
• Exhibit 89: Buchler GmbH - Product / Service
• Exhibit 90: Buchler GmbH - Key offerings
• 10.5 Cipla Ltd.
• Exhibit 91: Cipla Ltd. - Overview
• Exhibit 92: Cipla Ltd. - Business segments
• Exhibit 93: Cipla Ltd. - Key news
• Exhibit 94: Cipla Ltd. - Key offerings
• Exhibit 95: Cipla Ltd. - Segment focus
• 10.6 Ipca Laboratories Ltd.
• Exhibit 96: Ipca Laboratories Ltd. - Overview
• Exhibit 97: Ipca Laboratories Ltd. - Product / Service
• Exhibit 98: Ipca Laboratories Ltd. - Key offerings
• 10.7 Lark Laboratories India Ltd.
• Exhibit 99: Lark Laboratories India Ltd. - Overview
• Exhibit 100: Lark Laboratories India Ltd. - Product / Service
• Exhibit 101: Lark Laboratories India Ltd. - Key offerings
• 10.8 Merck and Co. Inc.
• Exhibit 102: Merck and Co. Inc. - Overview
• Exhibit 103: Merck and Co. Inc. - Business segments
• Exhibit 104: Merck and Co. Inc. - Key news
• Exhibit 105: Merck and Co. Inc. - Key offerings
• Exhibit 106: Merck and Co. Inc. - Segment focus
• 10.9 Merck KGaA
• Exhibit 107: Merck KGaA - Overview
• Exhibit 108: Merck KGaA - Business segments
• Exhibit 109: Merck KGaA - Key news
• Exhibit 110: Merck KGaA - Key offerings
• Exhibit 111: Merck KGaA - Segment focus
• 10.10 PRISM INDUSTRIES LTD.
• Exhibit 112: PRISM INDUSTRIES LTD. - Overview
• Exhibit 113: PRISM INDUSTRIES LTD. - Product / Service
• Exhibit 114: PRISM INDUSTRIES LTD. - Key offerings
• 10.11 Teva Pharmaceutical Industries Ltd.
• Exhibit 115: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 116: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 117: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 118: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 119: Teva Pharmaceutical Industries Ltd. - Segment focus
• 10.12 VIVAN Life Sciences Pvt. Ltd.
• Exhibit 120: VIVAN Life Sciences Pvt. Ltd. - Overview
• Exhibit 121: VIVAN Life Sciences Pvt. Ltd. - Product / Service
• Exhibit 122: VIVAN Life Sciences Pvt. Ltd. - Key offerings

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 123: Inclusions checklist
• Exhibit 124: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 125: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 126: Research methodology
• Exhibit 127: Validation techniques employed for market sizing
• Exhibit 128: Information sources
• 11.5 List of abbreviations
• Exhibit 129: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Disease Type - Market share 2021-2026 (%)
• Exhibits25: Data Table on Disease Type - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Disease Type
• Exhibits27: Data Table on Comparison by Disease Type
• Exhibits28: Chart on Malaria - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Malaria - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Malaria - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Malaria - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Arrhythmias - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Arrhythmias - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Arrhythmias - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Arrhythmias - Year-over-year growth 2021-2026 (%)
• Exhibits36: Market opportunity by Disease Type ($ million)
• Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits40: Chart on Geographic comparison
• Exhibits41: Data Table on Geographic comparison
• Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits78: Market opportunity By Geographical Landscape ($ million)
• Exhibits79: Impact of drivers and challenges in 2021 and 2026
• Exhibits80: Overview on Criticality of inputs and Factors of differentiation
• Exhibits81: Overview on factors of disruption
• Exhibits82: Impact of key risks on business
• Exhibits83: Vendors covered
• Exhibits84: Matrix on vendor position and classification
• Exhibits85: Bennet Pharmaceuticals Ltd. - Overview
• Exhibits86: Bennet Pharmaceuticals Ltd. - Product / Service
• Exhibits87: Bennet Pharmaceuticals Ltd. - Key offerings
• Exhibits88: Buchler GmbH - Overview
• Exhibits89: Buchler GmbH - Product / Service
• Exhibits90: Buchler GmbH - Key offerings
• Exhibits91: Cipla Ltd. - Overview
• Exhibits92: Cipla Ltd. - Business segments
• Exhibits93: Cipla Ltd. - Key news
• Exhibits94: Cipla Ltd. - Key offerings
• Exhibits95: Cipla Ltd. - Segment focus
• Exhibits96: Ipca Laboratories Ltd. - Overview
• Exhibits97: Ipca Laboratories Ltd. - Product / Service
• Exhibits98: Ipca Laboratories Ltd. - Key offerings
• Exhibits99: Lark Laboratories India Ltd. - Overview
• Exhibits100: Lark Laboratories India Ltd. - Product / Service
• Exhibits101: Lark Laboratories India Ltd. - Key offerings
• Exhibits102: Merck and Co. Inc. - Overview
• Exhibits103: Merck and Co. Inc. - Business segments
• Exhibits104: Merck and Co. Inc. - Key news
• Exhibits105: Merck and Co. Inc. - Key offerings
• Exhibits106: Merck and Co. Inc. - Segment focus
• Exhibits107: Merck KGaA - Overview
• Exhibits108: Merck KGaA - Business segments
• Exhibits109: Merck KGaA - Key news
• Exhibits110: Merck KGaA - Key offerings
• Exhibits111: Merck KGaA - Segment focus
• Exhibits112: PRISM INDUSTRIES LTD. - Overview
• Exhibits113: PRISM INDUSTRIES LTD. - Product / Service
• Exhibits114: PRISM INDUSTRIES LTD. - Key offerings
• Exhibits115: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits116: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits117: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits118: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits119: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits120: VIVAN Life Sciences Pvt. Ltd. - Overview
• Exhibits121: VIVAN Life Sciences Pvt. Ltd. - Product / Service
• Exhibits122: VIVAN Life Sciences Pvt. Ltd. - Key offerings
• Exhibits123: Inclusions checklist
• Exhibits124: Exclusions checklist
• Exhibits125: Currency conversion rates for US$
• Exhibits126: Research methodology
• Exhibits127: Validation techniques employed for market sizing
• Exhibits128: Information sources
• Exhibits129: List of abbreviations